德国29,284例1型糖尿病患儿治疗与结局质量中的地区剥夺与区域差异:一项横断面多中心DPV分析
该研究基于德国DPV登记库2015/2016年数据,纳入29,284例20岁以下1型糖尿病患儿,按地区多重剥夺指数五分位分组,分析地区剥夺与糖尿病照护指标的关系。结果显示,从剥夺程度最低到最高五分位,持续葡萄糖监测系统使用率从6.3%降至3.4%,长效胰岛素类似物使用率从80.8%降至64.3%,平均HbA1c从7.84%升至8.07%(62至65 mmol/mol),超重患病率从11.8%升至15.5%,而严重低血糖发生率从12.1降至6.9事件/100患者年。
要点
- 地区剥夺程度越高,持续葡萄糖监测系统和长效胰岛素类似物使用率越低。
- 地区剥夺程度越高,平均HbA1c和超重患病率越高。
- 严重低血糖发生率随地区剥夺程度升高而降低。
核心结论
- 地区剥夺不仅与儿童1型糖尿病的关键结局相关,也与治疗方式相关。
- 在德国最剥夺地区,持续葡萄糖监测系统和持续皮下胰岛素输注的可及性有待改善。
研究设计与样本
- 横断面多中心分析,基于德国DPV登记库2015/2016年数据。
- 纳入29,284例20岁以下、有德国居住记录的1型糖尿病患儿。
- 地区剥夺采用地区层面德国多重剥夺指数(GIMD 2010)五分位评估并分配给患者。
- 采用多变量线性、逻辑和泊松回归模型,调整性别、年龄、移民背景、糖尿病病程和德国联邦州。
主要发现
- 从剥夺程度最低到最高五分位,持续葡萄糖监测系统使用率从6.3%降至3.4%。
- 从剥夺程度最低到最高五分位,长效胰岛素类似物使用率从80.8%降至64.3%,速效胰岛素类似物使用率从74.7%升至79.0%。
- 从剥夺程度最低到最高五分位,平均HbA1c从7.84%升至8.07%(62至65 mmol/mol),超重患病率从11.8%升至15.5%。
- 从剥夺程度最低到最高五分位,严重低血糖发生率从12.1降至6.9事件/100患者年。
- 与其他参数的关联模式更复杂(如持续皮下胰岛素输注使用)或无统计学显著性。
临床怎么用
- 关注地区剥夺程度较高的1型糖尿病患儿,评估其持续葡萄糖监测系统和胰岛素类似物的可及性。
- 在资源匮乏地区可考虑优化持续葡萄糖监测系统和持续皮下胰岛素输注的配置以改善照护公平性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study analyzed whether area deprivation is associated with disparities in health care of pediatric type 1 diabetes in Germany. RESEARCH DESIGN AND METHODS: We selected patients <20 years of age with type 1 diabetes and German residence documented in the "diabetes patient follow-up" (Diabetes-Patienten-Verlaufsdokumentation [DPV]) registry for 2015/2016. Area deprivation was assessed by quintiles of the German Index of Multiple Deprivation (GIMD 2010) at the district level and was assigned to patients. To investigate associations between GIMD 2010 and indicators of diabetes care, we used multivariable regression models (linear, logistic, and Poisson) adjusting for sex, age, migration background, diabetes duration, and German federal state. RESULTS: We analyzed data from 29,284 patients. From the least to the most deprived quintile, use of continuous glucose monitoring systems (CGMS) decreased from 6.3 to 3.4% and use of long-acting insulin analogs from 80.8 to 64.3%, whereas use of rapid-acting insulin analogs increased from 74.7 to 79.0%; average HbA1c increased from 7.84 to 8.07% (62 to 65 mmol/mol), and the prevalence of overweight from 11.8 to 15.5%, but the rate of severe hypoglycemia decreased from 12.1 to 6.9 events/100 patient-years. Associations with other parameters showed a more complex pattern (use of continuous subcutaneous insulin infusion [CSII]) or were not significant. CONCLUSIONS: Area deprivation was associated not only with key outcomes in pediatric type 1 diabetes but also with treatment modalities. Our results show, in particular, that the access to CGMS and CSII could be improved in the most deprived regions in Germany.
引用
- Auzanneau M, Lanzinger S, Bohn B, et al. Area Deprivation and Regional Disparities in Treatment and Outcome Quality of 29,284 Pediatric Patients With Type 1 Diabetes in Germany: A Cross-sectional Multicenter DPV Analysis. Diabetes Care. 2018. PMID: 30327359. doi:10.2337/dc18-0724
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。